These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7984796

  • 1. [Clinical and serologic course of patients with mixed connective tissue disease].
    López-Longo FJ, Fernández J, Monteagudo I, Rodríguez-Mahou M, Sánchez-Atrio AI, Pérez T, Escalona M, González CM, Lapointe N, Carreño L.
    Rev Clin Esp; 1994 Sep; 194(9):682-8. PubMed ID: 7984796
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O.
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
    Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J.
    Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
    [Abstract] [Full Text] [Related]

  • 4. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W, Hermann J, Joch M, Kerl H, Graninger W.
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [Abstract] [Full Text] [Related]

  • 5. Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease.
    Houtman PM, Kallenberg CG, Limburg PC, Huitema MG, van Rijswijk MH, The TH.
    Clin Exp Immunol; 1985 Dec; 62(3):696-704. PubMed ID: 3910321
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
    Gaubitz M, Wegmann C, Schotte H, Willeke P, Domschke W.
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
    [Abstract] [Full Text] [Related]

  • 7. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR, Wang GS, Sharp GC, Hoffman RW.
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
    Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC.
    Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
    Habets WJ, de Rooij DJ, Hoet MH, van de Putte LB, van Venrooij WJ.
    Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
    Ikeda K, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H.
    J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
    [Abstract] [Full Text] [Related]

  • 11. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E, Szegedi G.
    Orv Hetil; 2002 Feb 03; 143(5):229-33. PubMed ID: 11875835
    [Abstract] [Full Text] [Related]

  • 12. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A, Rönnelid J, Gunnarsson I, Karlsson G, Berg L, Lundberg I.
    J Autoimmun; 1998 Oct 03; 11(5):503-8. PubMed ID: 9802936
    [Abstract] [Full Text] [Related]

  • 13. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan 03; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 14. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, van Venrooij WJ.
    Clin Exp Immunol; 1983 Oct 03; 54(1):265-76. PubMed ID: 6352106
    [Abstract] [Full Text] [Related]

  • 15. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients.
    Ginsburg WW, Conn DL, Bunch TW, McDuffie FC.
    J Rheumatol; 1983 Apr 03; 10(2):235-41. PubMed ID: 6864677
    [Abstract] [Full Text] [Related]

  • 16. [Characterization by immunoblotting (western blot) of anti-RNP antibodies in 36 connective tissue disease patients of whom 26 had mixed connective tissue disease. Comparison with 28 lupus patients with anti-Sm antibodies].
    Meyer O, Kuntz D, Kahn MF, Bourgeois R, Haim T.
    Rev Rhum Mal Osteoartic; 1989 Jan 03; 56(1):39-44. PubMed ID: 2727580
    [No Abstract] [Full Text] [Related]

  • 17. Fluctuation of anti-endothelial cell antibody titers in " mixed connective tissue disease.
    Lage LV, de Carvalho JF, Caleiro MT, Yoshinari NH, da Mota LM, Khamashta MA, Cossermelli W.
    Isr Med Assoc J; 2012 Feb 03; 14(2):84-7. PubMed ID: 22693786
    [Abstract] [Full Text] [Related]

  • 18. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G.
    J Clin Invest; 1997 Jul 01; 100(1):127-35. PubMed ID: 9202064
    [Abstract] [Full Text] [Related]

  • 19. "To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.
    Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M.
    Semin Arthritis Rheum; 2012 Feb 01; 41(4):589-98. PubMed ID: 21959290
    [Abstract] [Full Text] [Related]

  • 20. Mixed connective tissue disease: a disease entity?
    Shen N, Chen S, Yang H, Fan L.
    Chin Med J (Engl); 1998 Mar 01; 111(3):214-7. PubMed ID: 10374418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.